GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ibex Technologies Inc (TSXV:IBT) » Definitions » Cyclically Adjusted FCF per Share

Ibex Technologies (TSXV:IBT) Cyclically Adjusted FCF per Share : C$0.04 (As of Jan. 2024)


View and export this data going back to 1986. Start your Free Trial

What is Ibex Technologies Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Ibex Technologies's adjusted free cash flow per share for the three months ended in Jan. 2024 was C$0.006. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$0.04 for the trailing ten years ended in Jan. 2024.

During the past 12 months, Ibex Technologies's average Cyclically Adjusted FCF Growth Rate was 33.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 58.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 36.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Ibex Technologies was 58.70% per year. The lowest was 10.60% per year. And the median was 29.85% per year.

As of today (2024-06-07), Ibex Technologies's current stock price is C$1.44. Ibex Technologies's Cyclically Adjusted FCF per Share for the quarter that ended in Jan. 2024 was C$0.04. Ibex Technologies's Cyclically Adjusted Price-to-FCF of today is 36.00.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Ibex Technologies was 36.00. The lowest was 9.00. And the median was 19.00.


Ibex Technologies Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Ibex Technologies's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibex Technologies Cyclically Adjusted FCF per Share Chart

Ibex Technologies Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.03 0.04

Ibex Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.04 0.04 0.04 0.04

Competitive Comparison of Ibex Technologies's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Ibex Technologies's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ibex Technologies's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ibex Technologies's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Ibex Technologies's Cyclically Adjusted Price-to-FCF falls into.



Ibex Technologies Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ibex Technologies's adjusted Free Cash Flow per Share data for the three months ended in Jan. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=0.006/125.0724*125.0724
=0.006

Current CPI (Jan. 2024) = 125.0724.

Ibex Technologies Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201404 0.002 98.920 0.003
201407 0.011 99.315 0.014
201410 0.003 99.473 0.004
201501 -0.017 98.209 -0.022
201504 -0.009 99.710 -0.011
201507 0.035 100.579 0.044
201510 0.023 100.500 0.029
201601 0.025 100.184 0.031
201604 -0.006 101.370 -0.007
201607 0.001 101.844 0.001
201610 0.000 102.002 0.000
201701 0.012 102.318 0.015
201704 -0.004 103.029 -0.005
201707 0.001 103.029 0.001
201710 0.005 103.424 0.006
201801 -0.019 104.056 -0.023
201804 0.000 105.320 0.000
201807 0.018 106.110 0.021
201810 -0.013 105.952 -0.015
201901 0.019 105.557 0.023
201904 -0.013 107.453 -0.015
201907 -0.013 108.243 -0.015
201910 -0.001 107.927 -0.001
202001 0.023 108.085 0.027
202004 -0.003 107.216 -0.003
202007 0.033 108.401 0.038
202010 0.020 108.638 0.023
202101 -0.010 109.192 -0.011
202104 0.017 110.851 0.019
202107 0.011 112.431 0.012
202110 0.038 113.695 0.042
202201 0.052 114.801 0.057
202204 0.028 118.357 0.030
202207 0.025 120.964 0.026
202210 0.027 121.517 0.028
202301 -0.024 121.596 -0.025
202304 0.003 123.571 0.003
202307 0.046 124.914 0.046
202310 0.014 125.310 0.014
202401 0.006 125.072 0.006

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Ibex Technologies  (TSXV:IBT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Ibex Technologies's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1.44/0.04
=36.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Ibex Technologies was 36.00. The lowest was 9.00. And the median was 19.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Ibex Technologies Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Ibex Technologies's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ibex Technologies (TSXV:IBT) Business Description

Industry
Traded in Other Exchanges
Address
5485 Pare Street, Suite 100, Montreal, QC, CAN, H4P 1P7
Ibex Technologies Inc is a company engaged in the production and sale of diagnostic products. It manufactures and markets enzymes for biomedical use, through its subsidiaries. It also manufactures and markets a series of arthritis assays that have applications in osteoarthritis research. It sells two product lines namely, Enzymes for in-vitro diagnostics and research, and Tests for osteoarthritis research. The group provides services like Filing and lyophilization of disposable diagnostic components, and Custom fermentation and purification of enzymes for diagnostic companies. Geographically, the firm sells its products in Canada, Germany, the U.S., the U.K., and other countries of which the majority of the revenue is generated from the U.S.

Ibex Technologies (TSXV:IBT) Headlines

No Headlines